2021
DOI: 10.1159/000512969
|View full text |Cite
|
Sign up to set email alerts
|

Basis of Image Analysis for Evaluating Cell Biomaterial Interaction Using Brightfield Microscopy

Abstract: Medical imaging is a growing field that has stemmed from the need to conduct noninvasive diagnosis, monitoring, and analysis of biological systems. With the developments and advances in the medical field and the new techniques that are used in the intervention of diseases, very soon the prevalence of implanted biomedical devices will be even more significant. The implanted materials in a biological system are used in diverse fields, which require lengthy evaluation and validation processes. However, currently … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(4 citation statements)
references
References 123 publications
(135 reference statements)
0
4
0
Order By: Relevance
“…For the end‐point of the cytotoxicity tests, MTT tests were used instead. For validation of the metabolic activity results, bright field images of the cells were taken regularly and analysed as described elsewhere [17].…”
Section: Methodsmentioning
confidence: 99%
“…For the end‐point of the cytotoxicity tests, MTT tests were used instead. For validation of the metabolic activity results, bright field images of the cells were taken regularly and analysed as described elsewhere [17].…”
Section: Methodsmentioning
confidence: 99%
“…Complex systems for standardized biomaterials evaluation are being developed too. For instance, PANBioRA biomaterials risk assessment system has been developing a modular apparatus for preclinical material's evaluation using cutting edge technologies such as cytotoxicity monitoring using sensors (Chmayssem et al, 2021;Chmayssem et al, 2022), organ-on-a-chip models (Huang et al, 2021), and mathematical modelling (Uka et al, 2021;Šušteršič et al, 2021).…”
Section: Regulation and Standardizationmentioning
confidence: 99%
“…Among them, the PANBioRA project has developed a modular system for preclinical materials evaluation using cutting edge technologies, including cytotoxicity monitoring by means of sensors, 11,12 organ-on-a-chip models, 13 and mathematical modelling. 14,15…”
Section: Introductionmentioning
confidence: 99%
“…Among them, the PANBioRA project has developed a modular system for preclinical materials evaluation using cutting edge technologies, including cytotoxicity monitoring by means of sensors, 11,12 organ-on-a-chip models, 13 and mathematical modelling. 14,15 In the current work, we have described a new miniaturized and simplied genotoxicity testing system that saves space and can be observed using uorescence microscopy aer only 24 hours of incubation, thereby reducing the test time by two, as compared to the classic Ames test, and allowing for an easier readout that can be automatized by image analysis. In this test, S. typhimurium strain is pre-incubated with test chemicals and then deposited into agar-coated interconnected wells in a microuidic chip, allowing us to perform each test in triplicate using a single injection (Fig.…”
Section: Introductionmentioning
confidence: 99%